Citation Impact
Citing Papers
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
2013 Standout
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis
1999
Advances in combating fungal diseases: vaccines on the threshold
2006
Vulvovaginal candidosis
2007 Standout
Evidence that Members of the Secretory Aspartyl Proteinase Gene Family, in ParticularSAP2,Are Virulence Factors forCandidaVaginitis
1999
Induced humoral immunity and vaccination against major human fungal pathogens
2002
History and new insights into host defense against vaginal candidiasis
2004
Virulence factors of Candida albicans
2001 Standout
A role for antibodies in the generation of memory antifungal immunity
2003
The use of mucoadhesive polymers in vaginal delivery
2005
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
2011 Standout
Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature?
1997
Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model
2004
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Candida albicanspathogenicity mechanisms
2013 Standout
Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients
1994
Humic acids: Structural properties and multiple functionalities for novel technological developments
2015 Standout
A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models
2012
Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)
2008
Increased Resistance to Systemic Candidiasis in Athymic or Interleukin‐10–Depleted Mice
2000
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
2007 Standout
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Clove (Syzygium aromaticum): a precious spice
2014 Standout
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity
1997
Innate and adaptive determinants of host susceptibility to medically important fungi
2003
Relation between Recurrent Vulvovaginal Candidiasis, Vaginal Concentrations of Mannose-Binding Lectin, and a Mannose-Binding Lectin Gene Polymorphism in Latvian Women
2003
In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts
2003
Immunity in vaginal candidiasis
2005
Fungal vaccines: real progress from real challenges
2008
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Immunity to Candida albicans: Th1, Th2 cells and beyond
1999
Influenza virosomes as a vaccine adjuvant and carrier system
2011
Defining trained immunity and its role in health and disease
2020 Standout
Immunity to fungal infections
2011 Standout
THE PROTECTIVE IMMUNE RESPONSE AGAINST VAGINAL CANDIDIASIS: LESSONS LEARNED FROM CLINICAL STUDIES AND ANIMAL MODELS
2002
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria
2000
Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene
1999
Development of an insect model for the in vivo pathogenicity testing of yeasts
2000
The Potential Role of Cytokine Therapy for Fungal Infections in Patients with Cancer: Is Recovery from Neutropenia all that is Needed?
1998
Eugenol—From the Remote Maluku Islands to the International Market Place: A Review of a Remarkable and Versatile Molecule
2012 Standout
Some methods of estimating the inbreeding coefficient.
1953 Standout
A Vaccine and Monoclonal Antibodies That Enhance Mouse Resistance toCandida albicansVaginal Infection
1998
Melaleuca alternifolia(Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties
2006 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Candida-Specific Antibodies during Experimental Vaginal Candidiasis in Mice
2002
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Engineering microbial consortia: a new frontier in synthetic biology
2008 StandoutNobel
The pH of the Host Niche Controls Gene Expression in and Virulence of Candida albicans
1998
Reversible Self-Assembly: A Key Feature for a New Class of Autodelivering Therapeutic Peptides
2009
Limited Role of Secreted Aspartyl Proteinases Sap1 to Sap6 in Candida albicans Virulence and Host Immune Response in Murine Hematogenously Disseminated Candidiasis
2010
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies
1996
Candida albicansSecreted Aspartyl Proteinases in Virulence and Pathogenesis
2003
Aspergillus fumigatusand Aspergillosis
1999 Standout
Candida Infections of the Genitourinary Tract
2010
Antibody immunity and invasive fungal infections
1995
Guidelines for Treatment of Candidiasis
2004 Standout
Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of aCandida albicansVaccine
2002
The Secreted Aspartyl Proteinases Sap1 and Sap2 Cause Tissue Damage in an In Vitro Model of Vaginal Candidiasis Based on Reconstituted Human Vaginal Epithelium
2003
Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis
2001
Candida albicans adhesins: Biochemical aspects and virulence.
1997
In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
2012
Hidden Killers: Human Fungal Infections
2012 Standout
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis
2005 Standout
Avirulence of Candida albicans CaHK1 Mutants in a Murine Model of Hematogenously Disseminated Candidiasis
1999
Works of Daniela Adriani being referenced
Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis
1993
Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats
1997
Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4+T Cells and Possible Participation of Other Local Lymphocyte Effectors
2002
Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection
1993
Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection
1995
Intravaginal and Intranasal Immunizations Are Equally Effective in Inducing Vaginal Antibodies and Conferring Protection against Vaginal Candidiasis
2002
Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis
2003
Local Anticandidal Immune Responses in a Rat Model of Vaginal Infection by and Protection againstCandida albicans
2000
Selected animal models: vaginal candidosis, Pneumocystis pneumonia, dermatophytosis and trichosporosis.
1998
The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections
2000